Company / FCF Margin
Mirum Pharmaceuticals, Inc. FCF Margin History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
10.5%
FY2025
5-year range
-693.8% / 10.5%
FY2022-FY2025
Trend
+280.1%
vs FY2024
Sector context
#43 of 133
Health Care
What the data says
FCF Margin changed +280% YoY in FY2025, a notable deviation from the 3-year average annual change of +161%.
Based on SEC 10-K filings.
10.5% in FY2025 with a 3-year CAGR of +704.3%.
Improved from -38.1% to 10.5% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- +704.3pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#43 of 133 in Health CareTop 32% of 133This company 10.5% Sector average -632.8%
▼
+101.7% above sector average
Key checks
Key Insights
- Mirum Pharmaceuticals, Inc.'s fcf margin has grown for 3 consecutive years.
- In FY2025, fcf margin increased 280.1% year-over-year.
- Currently 643.4pp above the Health Care sector average.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -26.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 10.5% | +280.1% |
| FY2024 | 2.8% | +107.3% |
| FY2023 | -38.1% | +94.5% |
| FY2022 | -693.8% | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026